
Ellen Behrend, VMD, PhD, MS, DACVIM (SAIM), shares why she believes SGLT2 inhibitors could help more cats with diabetes receive treatment and discusses their potential role in managing complex cases, including cats with acromegaly.

Ellen Behrend, VMD, PhD, MS, DACVIM (SAIM), shares why she believes SGLT2 inhibitors could help more cats with diabetes receive treatment and discusses their potential role in managing complex cases, including cats with acromegaly.

With complication risk rising as anesthetic time increases, Rebecca A. Johnson, DVM, PhD, DACVAA, outlined practical steps to reduce peri-anesthetic risk in brachycephalic patients through careful planning, airway management, and recovery protocols, during a 2026 AVMA Convention session.

Ellen Behrend, VMD, PhD, MS, DACVIM (SAIM), explains which feline patients may benefit from SGLT2 inhibitors, outlines key contraindications, and discusses the evolving conversation around cats with ketones.

Anita Patel, DVM, senior director of clinical excellence at IndeVets, discusses the challenges of navigating organizational change, from aligning values and goals to supporting teams through periods of transition.

Dilara Kiran, DVM, MS, explains why policy engagement extends beyond federal government, highlighting opportunities for veterinary professionals to influence decisions within their practices, communities, and the broader profession, in this interview from the 2026 AVMA Convention.

Disney's vice president of Animals, Science and Environment made the case that the best animal care happens with animals, not to them, and that no one achieves it alone.

Do feline diabetes diets need to change when a cat starts an SGLT2 inhibitor? Ellen Behrend, VMD, PhD, MS, DACVIM (SAIM), discusses what veterinarians should consider when balancing dietary recommendations, gastrointestinal adverse effects, and DKA concerns.

Concerns about diabetic ketoacidosis, ketone monitoring, and cost may prevent some veterinarians from considering SGLT2 for cats with diabetes. Ellen Behrend, VMD, PhD, MS, DACVIM (SAIM), discusses what monitoring is needed and how reduced monitoring requirements may help make these medications more affordable for owners.

At the 2026 AVMA Convention, Will P. Rausch, DVM, DACVIM (Cardiology), discussed where NT-proBNP fits in feline cardiomyopathy screening and why the test should be used as part of a broader diagnostic approach.

More than 700 continuing-education sessions run across 5 days, July 10–14. Here are the ones to circle first, sorted by practice area, plus a handful that are easy to scroll past and worth catching.

A comparison of the 2025 and 2026 AVMA Convention programs reveals a growing focus on affordability and access, alongside increased programming on New World screwworm, disaster preparedness, and veterinary practice ownership.

Take a closer look at one of the most overlooked aspects of a practice transition in this episode of The Vet Blast Podcast, presented by dvm360.

Joe Smith, DVM, MPS, PhD, DACVIM, DACVCP, cVMA, explains intravenous regional limb perfusion in a dvm360 interview.

dvm360's annual conference in Missouri introduces the 2026 Veterinary Heroes and features unique opportunities to network and learn

Hosted by the North American Veterinary Community, the annual Veterinary Meeting & Expo will offer more than 1000 hours of continuing education.

Joe Smith, DVM, MPS, PhD, DACVIM, DACVCP, explains how transdermal drug delivery is administered and processed by various animal species, in a dvm360 interview.

Jessie Ziegler, DVM, MS, DACVIM (LAIM), discusses a key point of her recent lecture at the 2026 ACVIM Forum.

Joe Smith, DVM, MPS, PhD, DACVIM, DACVCP, cVMA, explains what makes alternative drug delivery unique vs standard drug delivery.

Results of a study on a GLP-1 therapy in development were presented during the 2026 ACVIM Forum.

The American College of Veterinary Internal Medicine (ACVIM) recognized 15 investigators at the 2026 ACVIM Forum in Seattle, Washington.

The investigation showed improved stool consistency and microbiome balance in cats and dogs.

Tiffany Tupler, DVM, CBCC-KA, HABc, and Kory Muto, PharmD, FAPC, join Adam Christman, DVM, MBA, to explain how high-quality compounded medications expand treatment options across species, improve compliance with pet-friendly flavors, and more.

The event held during the 2026 AVMA Convention will showcase AI, sustainability, antimicrobial stewardship, One Health, and new care models.

In a session on treating poisoned patients at 2026 Fetch Nashville, Renee Schmid, DVM, DABT, DABVT, explains how to be the voice of reason in a scene of panic.

The event will be held August 28-30, 2026, featuring keynotes, hands-on labs, lunch-and-learn sessions, and more.

Upcoming industry events for earning continuing education credits

Dottie Brown, DVM, MS, DACVS, discussed a couple of ways that Mars Veterinary Health practices sustainability throughout its network of veterinary clinics and hospitals, in a dvm360 interview.

RCVS Knowledge published a Contextualized Care Roadmap in 2025 that provides guidance that can be applied in the US.

The nonprofit association is holding a contest with the top 10 winners receiving recognition at its 2026 annual meeting in San Diego.

Sonya Gordon, DVM, DVSc, DACVIM (Cardiology); and Carol Reinero, DVM, PhD, DACVIM (Small Animal) will deliver morning lectures to kick off each day, while Bruce Nwadike, DVM, DACVS, MRCVS, presents workshops in orthopedic surgery.